Safety and immunogenicity following a homologous booster dose of CoronaVac in children and adolescents

Data on safety and immunity elicited by a third booster dose of inactivated COVID-19 vaccine in children and adolescents are scarce. Here we conducted a study based on a double-blind, randomised, placebo-controlled phase 2 clinical trial (NCT04551547) to assess the safety and immunogenicity of a thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lei, Wu, Zhiwei, Ying, Zhifang, Li, Minjie, Hu, Yuansheng, Shu, Qun, Li, Jing, Wang, Huixian, Zhang, Hengming, Jiao, Wenbin, Wang, Lin, Zhao, Yuliang, Gao, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663200/
https://www.ncbi.nlm.nih.gov/pubmed/36376310
http://dx.doi.org/10.1038/s41467-022-34280-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663200/
https://www.ncbi.nlm.nih.gov/pubmed/36376310
http://dx.doi.org/10.1038/s41467-022-34280-y

Ejemplares similares